Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 13 Issue: 6
Author(s): Roland Brandt
Affiliation:
Export Options
About this article
Cite this article as:
Brandt Roland, Meet Our Editorial Board Member, Current Neuropharmacology 2015; 13 (6) . https://dx.doi.org/10.2174/1570159X1306151126144206
DOI https://dx.doi.org/10.2174/1570159X1306151126144206 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
21
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Assortment of Human Amniotic Membrane and Curcumin: a Potential Therapeutic Strategy for Burn Wound Healing
Current Drug Therapy Role of Grina/Nmdara1 in the Central Nervous System Diseases
Current Neuropharmacology Design and Synthesis of New Selective P-gp Substrates and Inhibitors
Current Pharmaceutical Design Gemcitabine Interacts with Carbonate Apatite with Concomitant Reduction in Particle Diameter and Enhancement of Cytotoxicity in Breast Cancer Cells
Current Drug Delivery Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia
Current Neuropharmacology Internet Addiction: A Systematic Review of Epidemiological Research for the Last Decade
Current Pharmaceutical Design Therapy in Prion Diseases
Current Topics in Medicinal Chemistry Insights into the Pathogenesis and Intervention of Atherosclerosis
Vascular Disease Prevention (Discontinued) Patent Selections:
Recent Patents on Chemical Engineering Intrinsically Fluorescent Base-Discriminating Nucleoside Analogs
Mini-Reviews in Organic Chemistry Off-Label Trazodone Prescription: Evidence, Benefits and Risks
Current Pharmaceutical Design The Design and Development of Fesoterodine as a Prodrug of 5- Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine
Current Medicinal Chemistry Depression Under the Perspective of Oxytocin
Central Nervous System Agents in Medicinal Chemistry New Trends in the Treatment of Schizophrenia
CNS & Neurological Disorders - Drug Targets Promising Medications for Cocaine Dependence Treatment
Recent Patents on CNS Drug Discovery (Discontinued) Targeting Telomerase for Cancer Therapy
Current Cancer Therapy Reviews Meet Our Editorial Board Member
Current Pharmacogenomics and Personalized Medicine Denaturant Induced Equilibrium Unfolding and Conformational Transitional Studies of Germinated Fenugreek β-Amylase Revealed Molten Globule like State at Low pH
Protein & Peptide Letters Caregiver Burden in Fragile X Families
Current Psychiatry Reviews Drug Therapy in Schizophrenia
Current Pharmaceutical Design